Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo

被引:56
作者
Pawlowski, JE [1 ]
Taylor, DS [1 ]
Valentine, M [1 ]
Hail, ME [1 ]
Ferrer, P [1 ]
Kowala, MC [1 ]
Molloy, CJ [1 ]
机构
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,PRINCETON,NJ 08543
关键词
atherosclerosis; restenosis; remodeling; EGF; TGF-beta;
D O I
10.1172/JCI119575
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Vasoactive GTP-binding protein-coupled receptor agonists (e.g., angiotensin II [ALI] and alpha-thrombin) stimulate the production of mitogenic factors from vascular smooth muscle cells, In experiments to identify mitogens secreted from AII- or alpha-thrombin-stimulated rat aortic smooth muscle (RASM) cells, neutralizing antibodies directed against several growth factors (e.g., PDGF and basic fibroblast growth factor [basic FGF]) failed to inhibit the mitogenic activity of conditioned media samples derived from the cells, In this report, we found that polyclonal neutralizing antibodies directed against purified human placental basic FGF reduced the mitogenic activity of AII-stimulated RASM cell-conditioned media and in immunoblot experiments identified a 26-kD protein (14 kD under reducing conditions) that was distinct from basic FGF, After purification from RASM cell-conditioned medium, amino acid sequence analysis identified the protein as activin A, a member of the TGF-beta superfamily, Increased activin A expression was observed after treatment of the RASM cells with AII, alpha-thrombin, and the protein kinase C agonist PMA. In contrast, PDGF-BB or serum caused only a minor induction of this protein. Although activin A alone only weakly stimulated RASM cell DNA synthesis, it demonstrated a potent comitogenic effect in combination with either EGF or heparin-binding EGF-like growth factor in the RASM cells, increasing DNA synthesis by up to fourfold. Furthermore, in a rat carotid injury model, activin A mRNA was upregulated within 6 h after injury followed by increases in immunoreactive protein detected in the expanding neointima 7 and 14 d later. Taken together, these results indicate that activin A is a vascular smooth muscle cell-derived factor induced by vasoactive agonists that may, either alone or in combination with other vascular derived growth factors, have a role in neointimal formation after arterial injury.
引用
收藏
页码:639 / 648
页数:10
相关论文
共 64 条
[1]  
BAILEY WL, 1994, ATHEROSCLEROSIS, V111, P55
[2]   APOPTOSIS OF RAT VASCULAR SMOOTH-MUSCLE CELLS IS REGULATED BY P53-DEPENDENT AND P53-INDEPENDENT PATHWAYS [J].
BENNETT, MR ;
EVAN, GI ;
SCHWARTZ, SM .
CIRCULATION RESEARCH, 1995, 77 (02) :266-273
[3]   APOPTOSIS OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM NORMAL VESSELS AND CORONARY ATHEROSCLEROTIC PLAQUES [J].
BENNETT, MR ;
EVAN, GI ;
SCHWARTZ, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2266-2274
[4]  
BERK BC, 1990, J BIOL CHEM, V265, P17334
[5]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[6]   ENHANCEMENT OF INCISIONAL WOUND-HEALING AND NEOVASCULARIZATION IN NORMAL RATS BY THROMBIN AND SYNTHETIC THROMBIN RECEPTOR-ACTIVATING PEPTIDES [J].
CARNEY, DH ;
MANN, R ;
REDIN, WR ;
PERNIA, SD ;
BERRY, D ;
HEGGERS, JP ;
HAYWARD, PG ;
ROBSON, MC ;
CHRISTIE, J ;
ANNABLE, C ;
FENTON, JW ;
GLENN, KC .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1469-1477
[7]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]   THROMBIN RECEPTOR FUNCTION AND CARDIOVASCULAR-DISEASE [J].
COUGHLIN, SR .
TRENDS IN CARDIOVASCULAR MEDICINE, 1994, 4 (02) :77-83
[9]   G-protein coupled and tyrosine kinase receptors: Evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells [J].
Delafontaine, P ;
Anwar, A ;
Lou, H ;
Ku, L .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :139-145
[10]  
DUFF JL, 1995, CARDIOVASC RES, V30, P530